C.Q. PHARMACEUTICAL HOLDING CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.34 CNY | -0.56% |
|
-2.02% | +7.44% |
| Apr. 26 | C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Mar. 12 | C.Q. Pharma's Unit Gets Nod to Market Pregabalin Capsules | MT |
| Sales 2024 * | 90.58B 12.5B | Sales 2025 * | 102B 14.03B | Capitalization | 9.23B 1.27B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.1B 152M | Net income 2025 * | 1.29B 178M | EV / Sales 2024 * | 0.1 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.09 x |
| P/E ratio 2024 * |
8.34
x | P/E ratio 2025 * |
7.17
x | Employees | 13,809 |
| Yield 2024 * |
1.5% | Yield 2025 * |
1.69% | Free-Float | 34.4% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.56% | ||
| 1 week | -2.02% | ||
| Current month | +2.50% | ||
| 1 month | +5.12% | ||
| 3 months | +11.48% | ||
| 6 months | +0.95% | ||
| Current year | +7.44% |
1 week
5.28
5.55
1 month
5.005.55
Current year
4.285.55
1 year
4.288.33
3 years
4.288.33
5 years
4.288.33
10 years
4.2812.88
| Managers | Title | Age | Since |
|---|---|---|---|
Tian Qiu
DFI | Director of Finance/CFO | 38 | 22-03-09 |
Quan Yuan
CHM | Chairman | 55 | 17-09-14 |
| 34 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Quan Yuan
CHM | Chairman | 55 | 17-09-14 |
Yun Wei
BRD | Director/Board Member | 51 | 23-03-26 |
Shao Hong Li
BRD | Director/Board Member | 54 | 17-09-14 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 117 M€ | +1.11% | - | |
| 0.00% | 34 M€ | +2.14% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 5.34 | -0.56% | 17,920,690 |
| 24-04-25 | 5.37 | -0.19% | 10,309,400 |
| 24-04-24 | 5.38 | +0.94% | 10,812,090 |
| 24-04-23 | 5.33 | -1.66% | 14,609,500 |
| 24-04-22 | 5.42 | -0.55% | 16,983,100 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotes
C.Q. Pharmaceutical Holding Co., Ltd., formerly CHONGQING JIANFENG CHEMICAL CO., LTD, is a China-based company principally engaged in the wholesale and retail business of pharmaceuticals and medical devices. The Companyâs products include chemical drugs, biopharmaceuticals, Chinese traditional patent medicines, Chinese herbal medicines, medical devices, health products and cosmetics.
Sector
Pharmaceuticals
Calendar
2024-04-26
- Q4 2023 Earnings Release
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
5.34
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +7.44% | 1.27B | |
| +17.35% | 71.39B | |
| +2.39% | 25.1B | |
| +5.38% | 8.59B | |
| +6.69% | 8.19B | |
| -20.96% | 7.91B | |
| +0.49% | 4.54B | |
| +17.12% | 4.31B | |
| -3.38% | 3.93B | |
| -2.61% | 3.86B |
- Stock Market
- Equities
- 000950 Stock
